Henry Schein Stock - Thursday technical picture and volatility check
18.06.2026 - 18:48:15 | ad-hoc-news.deEdited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 16:40 UTC. Details in the imprint.
Henry Schein (US42548G1040) is trading in a consolidated range on the Nasdaq this week. With no fresh company announcements or major analyst actions reported on Thursday, the focus shifts to the stock's technical profile and recent volatility based on Nasdaq and market data.
All news and data on Henry Schein stock
Key figures, market reports and regulatory filings on Henry Schein stock are bundled in the ad hoc news topic overview and on the company’s investor relations pages.
What recent prices show
According to Nasdaq data, Henry Schein shares closed at $79.97 on 06/17/2026, with after-hours trading edging the quote to about $80.24. This keeps the stock below its 52-week high but clearly above the lower end of its yearly range.
MarketBeat and similar quote services also show that the recent daily move of around -1.5% on Wednesday fits into a broader pattern of moderate swings rather than sharp dislocations. Trading volumes remain close to the stock’s average, pointing to orderly market conditions.
Thursday focus on chart levels
On this Thursday, chart watchers look in particular at Henry Schein’s medium-term trend. Public charting services indicate the stock trades not far from its 50-day moving average and continues to hold above longer-term support zones watched by many investors.
Against this backdrop, short-term volatility in the shares has stayed contained compared with more cyclical segments of the Standard & Poor's 500 index, with beta readings historically below 1 in many data services. That profile often reflects a defensive healthcare-related business.
How analysts frame the stock
Although there are no major fresh upgrades or downgrades on Thursday, consensus data compiled by institutional tracking platforms show that Henry Schein is followed by a broad set of Wall Street and regional analysts. Recommendations cluster around neutral to positive territory in many overviews.
Some institutional databases list value-focused investors such as Pzena among notable shareholders, with single-digit percentage stakes. While that does not constitute a current catalyst, it illustrates that the stock is firmly embedded in long-only portfolios rather than purely short-term trading strategies.
The business behind the stock
Henry Schein generates most of its revenue by distributing dental and medical supplies and related equipment to practices, clinics and laboratories worldwide. The company also offers practice-management software and value-added services, positioning itself as a one-stop partner for healthcare professionals.
Where the stock trades today
The shares of Henry Schein (US42548G1040) trade on the Nasdaq at $79.97 as of 06/17/2026, 16:00 Eastern Time, based on the latest available regular-session close.
Henry Schein at a glance
- Company: Henry Schein Inc.
- ISIN: US42548G1040
- WKN: 897961
- Ticker: HSIC
- Venue: Nasdaq
- Price (as of 06/17/2026, 16:00 Eastern Time): 79.97 USD
- Market cap: around 10-11 billion USD (as of mid-June 2026, based on recent prices and share count)
- Sector / Industry: Health Care - Health Care Supplies / Distribution
- Index membership: Member of major US healthcare and mid-cap indices; not a constituent of the Standard & Poor's 500 index in all datasets
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
